NDLI: Relationship Between Hypermethylated MGMT Gene and Osteosarcoma Necrosis Rate After Chemotherapy

Please wait, while we are loading the content...

Inflammatory Breast Cancer—Comparing the Effectivity of Preoperative Docetaxel-Epirubicine Protocol to Conventional Antracycline-Containing Chemotherapy to Achieve Clinical Benefit and Complete Pathological Response

Molecular Characterization of 103 Ovarian Serous and Mucinous Tumors

Expression of CDX2 and Hepatocyte Antigen in Benign and Malignant Lesions of Gallbladder and Its Correlation with Histopathologic Type and Clinical Outcome

Embryonic Vasculogenesis in Nodular Melanomas and Tumour Differentiation

Parkin Gene Alterations in Ovarian Carcinoma from Northern Indian Population

Relationship Between Hypermethylated MGMT Gene and Osteosarcoma Necrosis Rate After Chemotherapy

Prognostic Significance of Carbonic Anhydrase IX (CA-IX), Endoglin (CD105) and 8-hydroxy-2′-deoxyguanosine (8-OHdG) in Breast Cancer Patients

Clinical and Prognostic Value of the Presence of Irregular Giant Nuclear Cells in pT1 Ovarian Clear Cell Carcinoma

Human Papillomavirus in Benign Prostatic Hyperplasia and Prostatic Adenocarcinoma Patients

The Evaluation of CD99 Immunoreactivity and EWS/FLI1 Translocation by Fluorescence in situ Hybridization in Central PNETs and Ewing’s Sarcoma Family of Tumors

Expression of 11β-hydroxysteroid Dehydrogenase Type 1 in Breast Cancer and Adjacent Non-Malignant Tissue. An Immunocytochemical Study

B-Raf Mutations, Microsatellite Instability and p53 Protein Expression in Sporadic Basal Cell Carcinomas

Immunoexpression of SALL4 in Wilms Tumors and Developing Kidney

Combined Inhibition of PI3K and mTOR Exerts Synergistic Antiproliferative Effect, but Diminishes Differentiative Properties of Rapamycin in Acute Myeloid Leukemia Cells

Detection of APC Gene Deletions in Colorectal Malignancies Using Quantitative PCR in a Chinese Population

Estrogen Receptor Negative and Progesterone Receptor Positive Breast Carcinomas—How Frequent are they?

CD1a and CD1d Genes Polymorphisms in Breast, Colorectal and Lung Cancers

Increased Expression of Toll-like Receptors (TLR) 2, 4 and 5 in Gastric Dysplasia

Expression of Tankyrase 1 in Gastric Cancer and Its Correlation with Telomerase Activity

Expressions of Topoisomerase IIα and BCRP in Metastatic Cells are Associated with Overall Survival in Small Cell Lung Cancer Patients

Expression and Amplification of Topoisomerase-2α in Type 1 and Type 2 Papillary Renal Cell Carcinomas and Its Correlation with HER2/neu Amplification

Extracellular Matrix Metalloproteinase Inducer is a Negative Prognostic Factor of Pediatric Medulloblastoma

Primary Peritoneal Serous Papillary Carcinoma: A Clinical and Pathological Study

Differential Biomarker Expression in Head and Neck Cancer Correlates with Anatomical Localization

Glucocorticoid Receptor Expression and Antiproliferative Effect of Dexamethasone on Human Melanoma Cells

Association of mtDNA D-Loop Polymorphisms with Risk of Gastric Cancer in Chinese Population

Effects of Homeodomain Protein CDX2 Expression on the Proliferation and Migration of Lovo Colon Cancer Cells

Female Breast Cancer Status According to ER, PR and HER2 Expression: A Population Based Analysis

Distribution, Incidence, and Prognosis in Neuroendocrine Tumors: a Population Based Study from a Cancer Registry

Study of the Differentially Expressed Genes in Pleomorphic Adenoma Using cDNA Microarrays

Cardiac Metastasis: A Rare Involvement of Primitive Neuroectodermal Tumour of the Lung

Giant Bilateral Symptomatic Adrenal Myelolipomas Associated with Congenital Adrenal Hyperplasia

Spontaneous Remission in Localized Diffuse Large B-cell Lymphoma

Pathology & Oncology Research : Volume 17, Issue 2, June 2011

Pathology & Oncology Research : Volume 17, Issue 1, March 2011

Pathology & Oncology Research : Volume 16

Pathology & Oncology Research : Volume 15

Pathology & Oncology Research : Volume 14

Pathology & Oncology Research : Volume 13

Pathology & Oncology Research : Volume 12

Pathology & Oncology Research : Volume 11

Pathology & Oncology Research : Volume 10

Pathology & Oncology Research : Volume 9

Pathology & Oncology Research : Volume 8

Pathology & Oncology Research : Volume 7

Pathology & Oncology Research : Volume 6

Pathology & Oncology Research : Volume 5

Pathology & Oncology Research : Volume 4

Pathology & Oncology Research : Volume 3

Relationship Between Hypermethylated MGMT Gene and Osteosarcoma Necrosis Rate After Chemotherapy

Content Provider	Springer Nature Link
Author	Cui, Qiu Jiang, Weihao Guo, Jun Liu, Cheng Li, Dingfeng Wang, Xiaohong Zeng, Yanjun
Copyright Year	2011
Abstract	To investigate the relativity of MGMT(O-6-methylguanine-DNA methyltransferase) gene methylation from patients with protein expression and osteosarcoma necrosis rate after chemotherapy. Fifty-one oteosarcoma tissues were collected, Methylation of MGMT gene promoter was detected by methylation-specific PCR method, and protein expression of MGMT was examined by immunohistochemistry procedure, the relationship between methylated MGMT gene expression and patients response to chemotherapy was analyzed. The positive ratio of methylation MGMT gene promoter in 51 patients was 23.5% (12 in 51). Negative percentage of protein expression of MGMT was 27.5% (14 in 51). It seemed that methylation of MGMT gene in osteosarcoma tissues had no evident relationship with the patient’s age, sexuality, and the size and type of neoplasms, etc. The necrosis rates of methylated MGMT of osteosarcoma (tumor grade from I to IV) were 0 (0/51), 3.9% (2/51), 5.9% (3/51), 13.7% (7/51), respectively. In contrast, the necrosis rates of unmethylated MGMT of osteosarcoma (tumor grade from I to IV) were 45.1% (23/51), 25.5% (13/51), 3.9% (2/51), 2.0% (1/51), respectively. It suggest that methylated and unmethylated MGMT gene of osteosarcoma have significant difference in protein expression. The unmethylated MGMT gene has higher positive protein expression (u = −4.92, P < 0.001). Methylation of MGMT gene has higher tumor necrosis rate in osteosarcoma patients. Methylation in MGMT promoter may be important for judging the effect of chemotherapy in Osteosarcoma patients.
Starting Page	587
Ending Page	591
Page Count	5
File Format	PDF
ISSN	12194956
Journal	Pathology & Oncology Research
Volume Number	17
Issue Number	3
e-ISSN	15322807
Language	English
Publisher	Springer Netherlands
Publisher Date	2011-03-20
Publisher Place	Dordrecht
Access Restriction	Subscribed
Subject Keyword	Osteosarcoma DNA methylation CpG island Drug resistance, Neoplasm O$^{6}$-Methylguanine-DNA Methyltransferase Pathology Immunology Oncology Cancer Research Biomedicine general
Content Type	Text
Resource Type	Article
Subject	Cancer Research Pathology and Forensic Medicine Oncology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Relationship between hypermethylated MGMT gene and osteosarcoma necrosis rate after chemotherapy.

Immunohistochemical Assessment of O(6)-Methylguanine-DNA Methyltransferase (MGMT) and Its Relationship with p53 Expression in Endometrial Cancers.

O6-Methylguanine-DNA Methyltransferase (MGMT): Challenges and New Opportunities in Glioma Chemotherapy

Research on DNA methylation of human osteosarcoma cell MGMT and its relationship with cell resistance to alkylating agents.

Methylation hot spots in the 5 flanking region denote silencing of the O 6 -methylguanine-DNA methyltransferase gene (1997)

1 carcinogenesis ms-carcin-2003-00018 cpg methylation-dependent repression of the human 0 6 –methylguanine-dna methyltransferase gene linked to chromatin structure alteration # (2003).

Clinicopathological significance and potential drug target of O6-methylguanine-DNA methyltransferase in colorectal cancer: a meta-analysis

Determining methylation status of methylguanine DNA methyl transferase (MGMT) from formalin-fixed, paraffin embedded tumor tissue

'MGMT for pt mgmt': is methylguanine-DNA methyltransferase testing ready for patient management?

Relationship Between Hypermethylated MGMT Gene and Osteosarcoma Necrosis Rate After Chemotherapy

Similar Documents

Relationship between hypermethylated MGMT gene and osteosarcoma necrosis rate after chemotherapy.

Immunohistochemical Assessment of O(6)-Methylguanine-DNA Methyltransferase (MGMT) and Its Relationship with p53 Expression in Endometrial Cancers.

O6-Methylguanine-DNA Methyltransferase (MGMT): Challenges and New Opportunities in Glioma Chemotherapy

Research on DNA methylation of human osteosarcoma cell MGMT and its relationship with cell resistance to alkylating agents.

Methylation hot spots in the 5 flanking region denote silencing of the O 6 -methylguanine-DNA methyltransferase gene (1997)

1 carcinogenesis ms-carcin-2003-00018 cpg methylation-dependent repression of the human 0 6 –methylguanine-dna methyltransferase gene linked to chromatin structure alteration # (2003).

Clinicopathological significance and potential drug target of O6-methylguanine-DNA methyltransferase in colorectal cancer: a meta-analysis

Determining methylation status of methylguanine DNA methyl transferase (MGMT) from formalin-fixed, paraffin embedded tumor tissue

'MGMT for pt mgmt': is methylguanine-DNA methyltransferase testing ready for patient management?

Relationship Between Hypermethylated MGMT Gene and Osteosarcoma Necrosis Rate After Chemotherapy